Showing results (31-40 of 195) with videos related to
Sort By:
Pageof 20
American Journal of Hematology|March 13, 2019
Accelerating chimeric antigen receptor therapy in chronic lymphocytic leukemia: The development and challenges of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemiaSteven M Bair, David L PorterExpert Review of Hematology|November 19, 2010
Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversiesSteven C Goldstein, David L PorterBest Practice & Research. Clinical Haematology|September 26, 2006
Donor leukocyte infusions in myeloid malignancies: new strategiesDavid L Porter, Joseph H AntinOncology (Williston Park, N.Y.)|October 17, 2016
The Promise of Chimeric Antigen Receptor T-Cell TherapyNoelle V Frey, David L PorterLeukemia Research Reports|September 3, 2014
High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failureMorgan B Smith, Elizabeth A Griffiths, James E Thompson, et al.Expert Opinion on Orphan Drugs|August 8, 2019
Bosutinib for the Treatment of Philadelphia Chromosome-Positive LeukemiasCristina Varallo-Rodriguez, Craig W Freyer, Evelena P Ontiveros, et al.Bone Marrow Transplantation|May 26, 2018
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tractAlex Ganetsky, Noelle V Frey, Elizabeth O Hexner, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2016
Chimeric Antigen Receptor T Cells and Hematopoietic Cell Transplantation: How Not to Put the CART Before the HorseSaad S Kenderian, David L Porter, Saar GillGene|June 7, 2011
An inhibitor of eIF2 activity in the sRNA pool of eukaryotic cellsMichael Centrella, David L Porter, Thomas L McCarthyBlood Reviews|November 18, 2015
Chimeric antigen receptor T cell therapy: 25years in the makingSaar Gill, Marcela V Maus, David L PorterPageof 20